BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.470
+0.030 (0.68%)
At close: Jun 6, 2025, 4:00 PM
4.680
+0.210 (4.70%)
After-hours: Jun 6, 2025, 7:23 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $159.53 million as of June 6, 2025.
Market Cap
159.53M
Enterprise Value
-165.23M
1-Year Change
n/a
Ranking
Category
Stock Price
4.47
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $159.53M, a decrease of -74.06%. That is a compound annual growth rate of -85.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 159.53M | -23.14% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.81B |
| Johnson & Johnson | 372.44B |
| AbbVie | 336.18B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.33B |
| Abbott Laboratories | 232.89B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |